Lexeo Therapeutics, Inc. (LXEO) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 58 transactions totaling $14.1M, demonstrating a bullish sentiment with $10.9M in net insider flow. The most recent transaction on Feb 18, 2026 involved a sale of 10,173 shares valued at $64.9K.
No significant insider buying has been recorded for LXEO in the recent period.
No significant insider selling has been recorded for LXEO in the recent period.
Based on recent SEC filings, insider sentiment for LXEO is bullish with an Insider Alignment Score of 89/100 and a net flow of $10.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Lexeo Therapeutics, Inc. (LXEO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading LXEO stock, having executed 58 transactions in the past 90 days. The most active insider is Venture Partners Iv, L.p. Longitude (Executive), who has made 3 transactions totaling $5.0M.
Get notified when executives and directors at LXEO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Nolan Townsend Richard | Executive | Sale | 10,173 | $6.38 | $64.9K | |
| Feb 18, 2026 | Manuel Otero Jose | Chief Operating Officer | Sale | 3,016 | $6.40 | $19.3K | C-Suite |
| Nov 18, 2025 | Robertson Jenny | Executive | Sale | 549 | $9.27 | $5.1K | |
| Nov 18, 2025 | Sandi See Tai | Executive | Sale | 386 | $9.27 | $3.6K | |
| Nov 18, 2025 | Adler Eric | Executive | Sale | 615 | $9.27 | $5.7K | |
| Nov 18, 2025 | Nolan Townsend Richard | Executive | Sale | 1,127 | $9.27 | $10.4K | |
| Oct 17, 2025 | Nolan Townsend Richard | Executive | Sale | 148 | $9.56 | $1.4K | |
| Oct 17, 2025 | Nolan Townsend Richard | Executive | Sale | 12,985 | $8.94 | $116.1K | |
| Oct 17, 2025 | Adler Eric | Executive | Sale | 3,344 | $8.94 | $29.9K | |
| Oct 17, 2025 | Adler Eric | Executive | Sale | 38 | $9.56 | $363 | |
| Oct 17, 2025 | Manuel Otero Jose | Executive | Sale | 24 | $9.56 | $229 | |
| Oct 17, 2025 | Manuel Otero Jose | Executive | Sale | 2,091 | $8.94 | $18.7K | |
| Oct 17, 2025 | Robertson Jenny | Executive | Sale | 3,486 | $8.94 | $31.2K | |
| Oct 17, 2025 | Robertson Jenny | Executive | Sale | 40 | $9.56 | $382 | |
| Oct 17, 2025 | Sandi See Tai | Executive | Sale | 3,844 | $8.94 | $34.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 3 | $12.5M | 88.4% |
Sale(S) | 32 | $1.6M | 11.1% |
Exercise(M) | 5 | $58.3K | 0.4% |
Award(A) | 11 | $5.8K | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insiders at Lexeo Therapeutics, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 58 transactions totaling $12.5M in purchases versus $1.6M in sales, the net buying activity of $10.9M signals strong executive confidence. Venture Partners Iv, L.p. Longitude (Executive) leads the buying activity with $5.0M in transactions across all time.